Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;10(6):356-64.
doi: 10.1038/nrrheum.2014.19. Epub 2014 Feb 18.

Emerging role of extracellular vesicles in inflammatory diseases

Affiliations
Review

Emerging role of extracellular vesicles in inflammatory diseases

Edit I Buzas et al. Nat Rev Rheumatol. 2014 Jun.

Abstract

The discovery that submicron-sized extracellular vesicles (EVs) are generated by both prokaryotic and eukaryotic cells might have a profound effect on experimental and clinical sciences, and could pave the way for new strategies to combat various diseases. EVs are carriers of pathogen-associated and damage-associated molecular patterns, cytokines, autoantigens and tissue-degrading enzymes. In addition to a possible role in the pathogenesis of a number of inflammatory conditions, such as infections and autoimmune diseases, EVs, including microvesicles (also known as microparticles), exosomes and apoptotic vesicles, have therapeutic potential and might be used as biomarkers for inflammatory diseases. Therefore, molecular diagnostics and targeted therapy could benefit from expanding knowledge in the field. In this Review, we summarize important developments and propose that extracellular vesicles could be used as therapeutic vehicles and as targets for the treatment and prevention of inflammatory diseases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 2009 Apr 15;182(8):5052-62 - PubMed
    1. Blood. 2008 Dec 15;112(13):5026-36 - PubMed
    1. Thromb Haemost. 2006 Jan;95(1):94-9 - PubMed
    1. Blood Coagul Fibrinolysis. 2009 Jan;20(1):63-70 - PubMed
    1. J Biol Chem. 2013 Apr 5;288(14):10093-10099 - PubMed

Publication types

MeSH terms